RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
TFOIX
Price
$50.76
Change
+$0.63 (+1.26%)
Updated
Sep 5 closing price
Net Assets
1.64B
Interact to see
Advertisement

RGEBX vs TFOIX

Header iconRGEBX vs TFOIX Comparison
Open Charts RGEBX vs TFOIXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
Transamerica Capital Growth I
Price$50.76
Change+$0.63 (+1.26%)
VolumeN/A
Net Assets1.64B
RGEBX vs TFOIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. TFOIX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and TFOIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. TFOIX (1.64B). RGEBX (0.00) and TFOIX (0.00) have matching dividends . RGEBX was incepted earlier than TFOIX: RGEBX (11 years) vs TFOIX (16 years). RGEBX (1.09) is less costly to investors than TFOIX (0.83). RGEBX is a more actively managed with annual turnover of: 25.00 vs. TFOIX (20.00). RGEBX has a lower initial minimum investment than TFOIX: RGEBX (250) vs TFOIX (1000000). TFOIX annual gain was more profitable for investors over the last year : 71.74 vs. RGEBX (17.32). RGEBX return over 5 years is better than : 38.39 vs. TFOIX (5.20).
RGEBXTFOIXRGEBX / TFOIX
Total Expense Ratio1.090.82133%
Annual Report Gross Expense Ratio1.090.83131%
Fund Existence11 years16 years-
Gain YTD15.13225.51359%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets332B1.64B20,195%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.3271.7424%
Returns for 3 years57.24125.4046%
Returns for 5 years38.395.20738%
Returns for 10 years91.0096.4394%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc